Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.34 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.32 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3865298 | 0.94 | EPHX1 (0.39) | EPHX1TSHRKDM4EMAPK1HIF1A | |
| SCHEMBL4637404 | 0.87 | EPHX1 (0.35) | EPHX1TSHRMEN1KMT2AALDH1A1 | |
| SCHEMBL20954114 | 0.86 | CYP2D6 (0.36) | EPHX1TSHRMEN1KMT2ACYP2D6 | |
| SCHEMBL254189 | 0.84 | EPHX1 (0.46) | EPHX1TSHRKDM4EMAPK1HIF1A | |
| SCHEMBL6948794 | 0.84 | EPHX1 (0.32) | EPHX1TSHRKDM4EMAPK1HIF1A | |
| SCHEMBL18180992 | 0.83 | TSHR (0.44) | EPHX1TSHRKDM4EMAPK1HIF1A | |
| SCHEMBL467687 | 0.83 | EPHX1 (0.55) | EPHX1TSHRKDM4EMAPK1HIF1A | |
| SCHEMBL960689 | 0.83 | KDM4E (0.56) | TSHRKDM4EMAPK1HIF1AALDH1A1 | |
| SCHEMBL10016193 | 0.81 | NPC1 (0.37) | EPHX1TSHRKDM4EMAPK1HIF1A | |
| SCHEMBL22174072 | 0.81 | TSHR (0.52) | TSHRKDM4EMEN1KMT2ALMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 237 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4747306-A1 | THERMALLY CONDUCTIVE TWO-COMPONENT COMPOSITION WITH CURING RETARDER | Sika Technology AG (CH) | 2026-05-27 | — | — | EP | claimed |
| WO-2025017022-A1 | THERMALLY CONDUCTIVE TWO-COMPONENT COMPOSITION WITH CURING RETARDER | SIKA TECHNOLOGY AG (CH) | 2025-01-23 | — | — | WO | claimed |
| EP-4495175-A1 | THERMALLY CONDUCTIVE TWO-COMPONENT COMPOSITION WITH CURING RETARDER | Sika Technology AG (CH) | 2025-01-22 | — | — | EP | claimed |
| CN-115626840-A | Concrete durability protection material for sewage treatment plant and application thereof | 重庆锦弘新材料技术工程有限公司 | 2023-01-20 | — | — | CN | claimed |
| US-20230002537-A1 | Organic-inorganic hybrid material, fabrication process of the same and its starting material | CHANDA CHEMICAL CORP. (TW) | 2023-01-05 | — | — | US | claimed |
| EP-3972945-A1 | FLEXIBLE MORTAR COMPOSITIONS | Sika Technology AG (CH) | 2022-03-30 | — | — | EP | claimed |
| US-20210070914-A1 | Organic-inorganic hybrid material, fabrication process of the same and its starting material | CHANDA CHEMICAL CORP. (TW) | 2021-03-11 | — | — | US | claimed |
| CN-111468044-A | Internal coil heating reactor and method for producing 3-isocyanatopropyl trimethoxy silane by using same | 江西宏柏新材料股份有限公司 | 2020-07-31 | — | — | CN | claimed |
| EP-3256535-B1 | ELASTOMERIC SILICONE EMULSION FOR COATING APPLICATIONS | WACKER CHEMIE AG (DE) | 2018-06-20 | — | — | EP | claimed |
| EP-3256535-A1 | ELASTOMERIC SILICONE EMULSION FOR COATING APPLICATIONS | Wacker Chemie AG (DE) | 2017-12-20 | — | — | EP | claimed |
| WO-2016128333-A1 | ELASTOMERIC SILICONE EMULSION FOR COATING APPLICATIONS | WACKER CHEMIE AG (DE) | 2016-08-18 | — | — | WO | claimed |
| EP-1937697-B1 | METHOD FOR PRODUCTION OF ISOCYANATOSILANES | MOMENTIVE PERFORMANCE MAT INC (US) | 2013-10-16 | — | — | EP | claimed |
| EP-1869058-B1 | PROCESS FOR MAKING SILYLISOCYANURATE | MOMENTIVE PERFORMANCE MAT INC (US) | 2009-12-16 | — | — | EP | claimed |
| EP-1885731-B1 | PROCESS FOR THE PRODUCTION OF ISOCYANATOSILANE AND SILYLISOCYANURATE | MOMENTIVE PERFORMANCE MAT INC (US) | 2009-11-11 | — | — | EP | claimed |
| US-20080248289-A1 | Zinc Oxide Nanoparticles | MERCK PATENT GESELLSCHAFT (DE) | 2008-10-09 | — | — | US | claimed |
| EP-0476564-B1 | Latent carbamate silicon coupling agents and process for preparation and use | OSI SPECIALTIES INC (US) | 1995-12-27 | — | — | EP | claimed |
| EP-0476564-A1 | Latent carbamate silicon coupling agents and process for preparation and use | OSi Specialties, Inc. (US) | 1992-03-25 | — | — | EP | claimed |
| EP-4739727-A1 | CURING AGENT COMPOSITION COMPRISING SALTS OF THIOCYANATE | Hilti Aktiengesellschaft (LI) | 2026-05-13 | — | — | EP | disclosed |
| US-5220047-A | CARBAMATE SILICON COMPOUNDS AS LATENT COUPLING AGENTS AND PROCESS FOR PREPARATION AND USE | UNION CARBIDE CHEMICALS & PLASTICS TECHNOLOGY CORPORATION (US) | 1993-06-15 | — | — | US | disclosed |
| EP-0476564-A1 | Latent carbamate silicon coupling agents and process for preparation and use | OSi Specialties, Inc. (US) | 1992-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230002537-A1 | Organic-inorganic hybrid material, fabrication process of the same and its starting material | INTS9, CA4, OR10J3 | EPHX1 3356/4885TSHR 4885/4885KDM4E 487/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.